|
HS Code |
595936 |
| Generic Name | Sulpiride |
| Brand Names | Dogmatil, Eglonyl, Sulpor |
| Drug Class | Atypical antipsychotic |
| Chemical Formula | C15H23N3O4S |
| Molecular Weight | 341.43 g/mol |
| Route Of Administration | Oral, intramuscular |
| Indications | Schizophrenia, depression, anxiety disorders |
| Mechanism Of Action | Dopamine D2 and D3 receptor antagonist |
| Half Life | 8-9 hours |
| Protein Binding | Approximately 40% |
| Metabolism | Minimal hepatic metabolism |
| Excretion | Primarily renal |
| Atc Code | N05AL01 |
As an accredited Sulpiride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for Sulpiride 50 mg tablets contains 30 tablets in a sealed blister pack, labeled with dosage and manufacturer information. |
| Shipping | Sulpiride is shipped as a pharmaceutical chemical in tightly sealed containers, protected from light, moisture, and extreme temperatures. All packages are clearly labeled according to regulatory guidelines, ensuring compliance with safety and transport regulations. Proper documentation and handling procedures are followed to guarantee safe delivery of Sulpiride to its destination. |
| Storage | Sulpiride should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), in a tightly closed container, protected from moisture, light, and heat. Keep it away from incompatible substances and out of reach of children. Avoid storing in the bathroom or areas prone to dampness. Ensure proper labeling and follow local regulations for storage and disposal. |
|
Purity 98%: Sulpiride with a purity of 98% is used in psychiatric treatment protocols, where it ensures consistent therapeutic efficacy and patient safety. Molecular Weight 341.48 g/mol: Sulpiride with a molecular weight of 341.48 g/mol is used in oral tablet formulations, where precise dosing improves pharmacokinetic reliability. Melting Point 178°C: Sulpiride with a melting point of 178°C is used in solid-state manufacturing processes, where stable compound integration enhances quality control. Particle Size 50 μm: Sulpiride with a particle size of 50 μm is used in granulation for capsule production, where uniform dispersion improves bioavailability. Stability Temperature 25°C: Sulpiride with a stability temperature of 25°C is used in long-term storage conditions, where chemical integrity is maintained over extended shelf life. Solubility 1 mg/mL (water): Sulpiride with a solubility of 1 mg/mL in water is used in injectable solutions, where rapid dissolution ensures effective delivery. Viscosity Grade Low: Sulpiride with a low viscosity grade is used in liquid suspension formulations, where easy handling and accurate dosing are achieved. Assay 99%: Sulpiride with an assay value of 99% is used in regulated pharmaceutical manufacturing, where high assay purity guarantees compliance with industry standards. pH Stability Range 4-7: Sulpiride with a pH stability range of 4-7 is used in buffered preparations, where consistent potency is preserved across physiological conditions. Optical Rotation -: Sulpiride with neutral optical rotation is used in chiral drug synthesis, where absence of enantiomeric excess minimizes unwanted side reactions. |
Competitive Sulpiride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every so often, a medication emerges that reshapes the way we look at mental health treatment. Sulpiride belongs in that conversation, especially for people managing mood disorders and certain mental health conditions. This compound catches attention for its ability to help with symptoms that leave many feeling stuck—both for those struggling with persistent anxiety and those hit hard by the weight of depression or the confusion of psychotic episodes. It isn’t new, and it’s not the most famous antipsychotic, but years of clinical use and research have shown that sulpiride deserves respect.
There’s an overwhelming variety of medications on pharmacy shelves dole out for problems like schizophrenia or chronic anxiety. Drugs like risperidone, quetiapine, and olanzapine usually make the news, but sulpiride often slips by quietly, working for people who haven’t had luck with other options. It’s a selective dopamine D2/D3 receptor antagonist, meaning that it targets certain brain pathways responsible for symptoms of psychosis, agitation, and severe depression. Its selective action means fewer of the sedating effects people complain about with some other antipsychotics, making day-to-day living a possibility for many.
In my own interactions with patients and long conversations with colleagues, sulpiride stands out as a go-to for individuals who just can’t handle feeling groggy or tired all day. Others appreciate that they haven’t noticed as much weight gain or other metabolic disruptions—common complaints with the newer atypical antipsychotics. While it’s an older option in some countries, experience and time have put it on solid footing among clinicians balancing both safety and a patient’s quality of life.
Sulpiride typically comes in oral tablet and capsule form, sometimes available in doses ranging from 50 to several hundred milligrams. Dosing depends on what a person needs, how their body responds, and how much their daily life is affected by their symptoms. Higher doses usually go to those tackling psychosis, while lower doses may bring relief to those with persistent depressive symptoms or hard-to-treat anxiety. What’s practical about sulpiride is its flexibility—clinicians can titrate up or down depending on the effect, without needing complex blood monitoring or frequent lab checks.
Tablet shape, pill size, and dose flexibility can sound trivial to outsiders, but anyone who takes medication every day knows these details can become make-or-break. People who’ve been through medication rounds often say they like being able to split or adjust their dose with sulpiride. Most forms don’t require refrigeration, storage is straightforward, and shelf life holds up as long as pills stay dry and kept away from direct sunlight or excess heat.
Doctors tend to reach for sulpiride for people with a long history of failed treatments or when lighter interventions didn’t get the job done. I remember conversations with several patients who felt sidelined by constant sleepiness or extreme changes in appetite when on other antipsychotic medicines. Sulpiride delivered enough symptom relief without completely pulling the rug out from under their energy levels or daily motivation.
It’s popular in regions where healthcare budgets require careful choice—offering proven results without the high cost of some newer psychiatric drugs. In countries where it’s prescribed regularly, families sometimes recognize sulpiride as a lifeline that breaks a cycle of hospital stays and frustrating guesswork. The feeling of clarity after months or years of brain fog can be life changing.
No medication solves everything, and sulpiride comes with its own set of risks. Some people develop tremors or muscle stiffness with longer usage. These extrapyramidal side effects often show up when doses go high or when a person is also taking other dopamine-active medications. Sexual side effects may be a concern, and for a small fraction, the benefits don’t outweigh the daily functional difficulties. Prolactin levels can spike, and in some cases, changes in menstrual cycles or unexpected breast milk production have to be addressed openly between doctors and patients.
These aren’t just bullet points in a package insert. In real life, every extra appointment or frustrating side effect can erode a person’s trust in the process. That’s what makes honest, experienced clinical judgement valuable when sulpiride is on the table as a treatment plan.
Choosing medication always hinges on trust, experience, and context. Sulpiride becomes appealing when patients can’t handle persistent fatigue or fog brought on by alternatives. While newer antipsychotics arrive with glossy marketing, their broader receptor action can bring a higher chance of diabetes, cholesterol spikes, or rapid weight increase. Sulpiride has carved its spot for those who want a calmer lift without the metabolic trade-off.
Doctors often experiment with alternative doses or combinations, especially for tough cases that don’t fit textbook patterns. Flexibility on dosing means that a seasoned prescriber fine-tunes a regimen to meet the real needs—not just the numbers in a chart. There’s a certain freedom in not having to endlessly chase lab results or force a person to drastically change their daily life. For working adults, students, or caregivers, that matters. It’s not always the best fit for everyone, but being able to pivot or scale a dose up and down without a maze of red tape counts as a win.
Head-to-head, sulpiride holds its own against antipsychotics that revolutionized care in the last two decades. Risperidone and olanzapine attract attention for being “atypical”—promising fewer Parkinson’s-like symptoms—but they often fall short in managing metabolic issues, especially in younger adults. Sulpiride’s classic approach, focused on the dopamine pathway, means less interference with blood sugar or cholesterol. That adds up in the long run for people who stick with medication for years.
Another difference crops up in mental sharpness. Many patients report feeling less sedated, more present, and more able to participate in everyday activities while on sulpiride. Standard side effects seen with drugs like chlorpromazine—perpetual drowsiness, slurred speech, or emotional dampening—don’t show up as frequently or as severely. Still, no medicine skirts risk; concern over movement disorders keeps clinicians vigilant and ready to act if they catch early warning signs.
Medication only matters if it lets people live better. That sometimes means managing a full-time job, keeping up with children, or simply being able to get out of bed in the morning. I’ve seen sulpiride help people reconnect—regaining friendships, holding onto hobbies, or just enjoying music without feeling underwater. The stigma around mental health medications lingers, but when sulpiride enters the conversation, I’ve noticed a cautious optimism from families desperate for a reliable solution.
This isn’t just about numbers or statistics. For me, the stories carry more weight than any medication chart. I remember a young teacher who’d been sidelined for months after other medications made concentration impossible. Sulpiride turned the volume down on her anxiety without muting her drive or ability to focus. Another person, wrestling with fear so strong he could barely leave the house, gradually rebuilt routines and relationships. These aren’t isolated flukes—they reflect what can happen when the right tool lands in the right hands.
Medication success doesn’t stop with chemistry. Affordability or insurance hassles often tip the balance of whether someone sticks with treatment or gives up. Branded and generic versions of sulpiride often cost less than newer, patented drugs, making it a plausible choice in a wide range of health systems. Some regions report stable supply chains because the compound isn’t swept up in the shortages or recalls that dog other psychiatric meds. This practical stability has given it a solid reputation among discharge planners and family doctors.
Countless studies examine the benefits and trade-offs of antipsychotics, but I trust evidence built up by thousands of patients over decades. Headache specialists, psychiatrists, and general practitioners consistently report sulpiride as a middle-ground solution—strong enough to manage daunting symptoms, gentle enough that people don’t lose touch with themselves. The research reflects what I’ve seen: rates of hospitalization and relapse drop with the right dose and regular follow-up.
Science has tracked prolactin level changes, motor disturbances, and response rates high enough to keep sulpiride in clinical guidelines, especially in European and Asian countries. There’s less evidence out of the United States, as regulatory patterns and industry momentum tend to propel newer drugs into the spotlight. But doctors and pharmacists elsewhere continue to put their trust in its predictable results.
No single treatment solves every problem. Sulpiride’s success depends on honest conversation, clear education, and partnership between patient and doctor. Better side effect tracking and proactive communication help people stick with a plan even when challenges pop up. Eventually, newer drugs may outpace sulpiride in market share, but for now, its selective action and stability offer important advantages.
Improving access to sulpiride starts with clear communication among health policy leaders, pharmaceutical manufacturers, and community advocates. Ensuring stable price points and wide supply means fewer patients face abrupt changes or dangerous withdrawal periods. Investment in ongoing research to further reduce movement-related side effects or develop new formulations—like long-acting injectables—could provide even more freedom for those seeking normalcy.
It’s easy to get swept up by glossy pharmaceutical ads and promises of miracle cures. The truth sits in small victories: a mother able to attend her child’s school event, a young adult juggling work and friendships again, an elder reclaiming hobbies long set aside. These are wins that come from careful listening and tailoring treatment, not just reading a guideline or protocol.
Checking in often, ready to tweak doses or troubleshoot unexpected side effects, forms the backbone of long-term success with medications like sulpiride. It means trusting experience and finding a rhythm where drug therapy supports life, not just manages symptoms.
Medications come and go, but some stick around for a reason. Sulpiride isn’t about flashy marketing or chasing the trendiest research. Its quiet effectiveness, built on years of feedback and steadily growing data, speaks louder than any press release. For many, it represents hope—a way to at last see a future where work, relationships, and joy aren’t blocked by the heavy fog of mental illness.
Looking ahead, the best solutions include both keepers like sulpiride and the next generation of psychiatric innovation. For now, there’s wisdom in remembering what works. In countless living rooms and doctor’s offices, the story of sulpiride is still being written—patient by patient, life by life, hope renewed through experience and trust.